Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Canada’s new blood screening policy will not focus on sexual orientation. How does it compare with U.K. and U.S. rules?
A new exhibition and book showcase 165 AIDS posters from the University of Rochester’s vast online collection. [SLIDESHOW]
Bob Leahy reflects on a life-changing experience that altered the course of his HIV advocacy.
The HIV community will once again gather in person at AIDS 2022 next summer, but the conference will also have a virtual component.
The 24th International AIDS Conference will take place in Montreal, Canada, and virtually from 29 July to 2 August 2022.
Bob Leahy’s personal story illustrates how the rollout of COVID-19 vaccines in Canada exposes privilege, ageism and inequities.
This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.
Plus, advocates in Canada want health officials there to also allow more gay and bi men to donate blood.
In the United States, an FDA expert advisory panel voted on December 10 to recommend emergency use authorization.
The 90-90-90 HIV targets expire at the end of 2020. Bob Leahy looks at what comes next and what role people living with HIV can play.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
Intergenerational learning is vital. Here are six ideas I hope to convey during an upcoming youth HIV leadership conference.
The need for HIV self-testing has increased amid the COVID-19 pandemic.
Hint: It starts with three letters.
You’ve heard about the 90-90-90 HIV targets. But what about measuring quality of life? Bob Leahy wonders about adding a fourth 90.
As overdose death rates have risen in this population, life expectancy has increasingly narrowed.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.